JP2025515470A5 - - Google Patents

Info

Publication number
JP2025515470A5
JP2025515470A5 JP2024563188A JP2024563188A JP2025515470A5 JP 2025515470 A5 JP2025515470 A5 JP 2025515470A5 JP 2024563188 A JP2024563188 A JP 2024563188A JP 2024563188 A JP2024563188 A JP 2024563188A JP 2025515470 A5 JP2025515470 A5 JP 2025515470A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
cdr
domain includes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024563188A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025515470A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/019989 external-priority patent/WO2023212056A2/en
Publication of JP2025515470A publication Critical patent/JP2025515470A/ja
Publication of JP2025515470A5 publication Critical patent/JP2025515470A5/ja
Pending legal-status Critical Current

Links

JP2024563188A 2022-04-27 2023-04-26 サイトカイン融合タンパク質とcd8抗原結合分子の併用 Pending JP2025515470A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263335697P 2022-04-27 2022-04-27
US63/335,697 2022-04-27
PCT/US2023/019989 WO2023212056A2 (en) 2022-04-27 2023-04-26 Combination of cytokine fusion proteins with cd8 antigen binding molecules

Publications (2)

Publication Number Publication Date
JP2025515470A JP2025515470A (ja) 2025-05-15
JP2025515470A5 true JP2025515470A5 (cg-RX-API-DMAC7.html) 2026-05-11

Family

ID=88519563

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024563188A Pending JP2025515470A (ja) 2022-04-27 2023-04-26 サイトカイン融合タンパク質とcd8抗原結合分子の併用

Country Status (9)

Country Link
US (1) US20250339519A1 (cg-RX-API-DMAC7.html)
EP (1) EP4514397A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025515470A (cg-RX-API-DMAC7.html)
KR (1) KR20250027597A (cg-RX-API-DMAC7.html)
CN (1) CN119546343A (cg-RX-API-DMAC7.html)
AU (1) AU2023259161A1 (cg-RX-API-DMAC7.html)
CA (1) CA3250301A1 (cg-RX-API-DMAC7.html)
TW (1) TW202400664A (cg-RX-API-DMAC7.html)
WO (1) WO2023212056A2 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230112632A (ko) 2020-10-23 2023-07-27 애셔 바이오테라퓨틱스, 인크. 면역 세포 기능을 조절하기 위한 cd8 항원 결합 분자와의 융합
WO2026162740A1 (en) * 2025-01-31 2026-08-06 Astrazeneca Ab Cd8-binding cytokine engager combination therapies

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200306301A1 (en) * 2017-07-03 2020-10-01 Torque Therapeutics, Inc. Polynucleotides Encoding Immunostimulatory Fusion Molecules and Uses Thereof
JP2020533971A (ja) * 2017-08-28 2020-11-26 アルター・バイオサイエンス・コーポレーション Il−15をベースとするil−7及びil−21への融合物
JP7778571B2 (ja) * 2019-06-05 2025-12-02 アッシャー バイオセラピューティクス, インコーポレイテッド 免疫細胞機能をモジュレートするための変異体インターロイキン-2ポリペプチドと抗原結合分子の融合体
EP4175979A2 (en) * 2020-07-02 2023-05-10 Inhibrx, Inc. Polypeptides comprising modified il-2 polypeptides and uses thereof
KR20230086765A (ko) * 2020-10-13 2023-06-15 얀센 바이오테크 인코포레이티드 분화 클러스터 iv 및/또는 viii을 조절하기 위한 바이오-조작된 t 세포 매개 면역, 물질 및 기타 방법
KR20230112632A (ko) * 2020-10-23 2023-07-27 애셔 바이오테라퓨틱스, 인크. 면역 세포 기능을 조절하기 위한 cd8 항원 결합 분자와의 융합
WO2022245500A1 (en) * 2021-05-19 2022-11-24 Asher Biotherapeutics, Inc. Il-21 polypeptides and targeted constructs

Similar Documents

Publication Publication Date Title
JP6216940B2 (ja) ラクダ科動物由来の抗原結合ポリペプチド
JP2024175003A5 (cg-RX-API-DMAC7.html)
JP2024009962A5 (cg-RX-API-DMAC7.html)
JP2024167313A5 (cg-RX-API-DMAC7.html)
JP2020122013A5 (cg-RX-API-DMAC7.html)
RU2018146050A (ru) Биспецифические связывающие белки, которые связывают иммуномодулирующий белок и опухолевый антиген
RU2020124191A (ru) Анти-tigit антиген-связывающие белки и способы их применения
JP2021524278A5 (cg-RX-API-DMAC7.html)
JP2024522069A5 (cg-RX-API-DMAC7.html)
JP2017522892A5 (cg-RX-API-DMAC7.html)
RU2010150348A (ru) Антитела к рецептору конечных продуктов глубокого гликирования (rage) и их применение
AR126758A2 (es) Anticuerpos anti-ly6g6d y métodos de uso
JP2025063183A5 (cg-RX-API-DMAC7.html)
JP2021520832A5 (cg-RX-API-DMAC7.html)
RU2004135103A (ru) Антитела, специфичные к cd22 человека, и их применения в терапии и диагностике
JP2024086870A5 (cg-RX-API-DMAC7.html)
JP2010524435A5 (cg-RX-API-DMAC7.html)
HRP20191219T1 (hr) Molekule protutijela koje imaju specifičnost za ljudski ox40
RU2018126318A (ru) Молекулы полиспецифичных антител, имеющие специфичность к tnf-альфа, il-17a и il-17f
RU2003100512A (ru) Антитела к человеческому мср-1
JP2022505445A5 (cg-RX-API-DMAC7.html)
RU2019124709A (ru) КОМПОЗИЦИИ И СПОСОБЫ, СВЯЗАННЫЕ СО СКОНСТРУИРОВАННЫМИ КОНСТРУКЦИЯМИ НА ОСНОВЕ Fc-АНТИГЕНСВЯЗЫВАЮЩЕГО ДОМЕНА
JP2020522473A5 (cg-RX-API-DMAC7.html)
JP2022501065A5 (cg-RX-API-DMAC7.html)
JP2023553694A5 (cg-RX-API-DMAC7.html)